CTI Life Sciences Fund
CTI makes venture capital investments mostly in biotech companies at the pre-clinical and clinical development stages.
Business Model:
Revenue: $12.2M
Employees: 2-10
Rankings
Industries / Tags:
Detailed CTI Life Sciences Fund Information
Geographic Data
Address: 1 Place Ville-Marie
City: Montréal
State: prince edward island
Zip: H3B 2B6
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$195M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $345 million of assets.
Contact Phone:
+15147982333
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2012 | GLyPharma Therapeutic | Series A | 12.2M |
| 8/2016 | ILKOS Therapeutic | Series A | 21M |
| 4/2016 | DalCor Pharmaceuticals | Series B | 100M |
| 1/2023 | Amolyt Pharma | Series C | 0 |
| 7/2007 | TargeGen | Series D | 40M |
| 3/2017 | CellAegis Devices | Series C | 9.5M |
| 6/2016 | IMV Inc | Post-IPO Equity | 6.3M |
| 5/2022 | Domain Therapeutics | Series A | 0 |
| 9/2011 | Medicago | Post-IPO Equity | 0 |
| 6/2017 | PHEMI | Series B | 0 |
| 10/2007 | Chlorion Pharma | Venture Round | 6M |
| 7/2015 | Xagenic | Series B | 11.8M |
| 10/2020 | Phenomic AI | Seed | 6M |
| 10/2017 | Visterra | Series C | 0 |
| 7/2017 | PreciThera | Series A | 28.7M |
| 7/2015 | Vaxcyte | Series A | 22M |
| 9/2010 | NeurAxon | Debt Financing | 0 |
| 8/2015 | PHEMI | Series A | 0 |
| 8/2007 | Enobia Pharma | Series B | 37.8M |
| 8/2020 | Find therapeutics | Seed Round | - |
| 1/2012 | Xagenic | Series A | 0 |
| 3/2017 | Vaxcyte | Series B | 60M |
| 2/2010 | Somnusthera | Series A | 15M |
| 4/2022 | Epitopea | Seed Round | 0 |
| 4/2015 | Profound Medical Inc | Venture Round | 0 |
| 6/2015 | XTuit Pharmaceuticals | Series A | 22M |
| 3/2020 | Vaxcyte | Series D | 0 |
| 1/2015 | Zymeworks | Venture Round | 0 |
| 10/2014 | Visterra | Series B | 30M |
| 6/2020 | Phenomic AI | Seed Round | 3.4M |
| 6/2016 | Visterra | Series C | 23.1M |
| 6/2018 | Phenomic AI | Seed Round | 2M |
| 1/2016 | Zymeworks | Series A | 0 |
| 5/2022 | Domain Therapeutics | Series A | 0 |
| 4/2022 | Epitopea | Seed Round | 0 |
| 10/2020 | Phenomic AI | Seed Round | 0 |
| 8/2020 | Find therapeutics | Seed Round | - |
| 6/2020 | Phenomic AI | Seed Round | 0 |
| 3/2020 | Vaxcyte | Series D | 0 |
| 6/2018 | Phenomic AI | Seed Round | 0 |
| 10/2017 | Visterra | Series C | 0 |
| 7/2017 | PreciThera | Series A | 0 |
| 6/2017 | PHEMI | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
